Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1274 | 1125 | 1304 | 1490 | 1810 | 3612 |
Fund Return | 27.36% | 12.51% | 30.42% | 14.21% | 12.6% | 13.7% |
Place in category | 732 | 181 | 749 | 172 | 541 | 152 |
% in Category | 61 | 13 | 66 | 19 | 64 | 31 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TD Dividend Growth I | 11.11B | 21.50 | 10.14 | 7.44 | ||
TD Dividend Growth F | 11.11B | 22.80 | 11.41 | 8.67 | ||
TD Dividend Growth S | 11.11B | 22.78 | 11.60 | 8.73 | ||
TD Dividend Growth Fund Premium F | 11.11B | 22.86 | 11.47 | 8.74 | ||
TD Dividend Growth Fund Premium s | 11.11B | 21.56 | 10.19 | 7.50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PH N US Multi Style All Cap Eq D | 9.98B | 34.85 | 14.50 | 13.76 | ||
PH N US Multi Style All Cap Eq F | 9.98B | 35.14 | 14.77 | 14.04 | ||
TD U.S. Blue Chip Equity Fund D CAD | 6.16B | 25.43 | 5.60 | - | ||
TD U.S. Blue Chip Equity Fund I CAD | 6.16B | 24.25 | 4.59 | 13.59 | ||
RBC Priv US Lg Cap Cr Eq Sr F CAD | 5.91B | 34.43 | 14.79 | 14.37 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 8.50 | 509.55 | +0.68% | |
Goldman Sachs | US38141G1040 | 7.55 | 581.16 | -0.28% | |
Microsoft | US5949181045 | 7.46 | 439.71 | +0.09% | |
Home Depot | US4370761029 | 5.75 | 395.51 | -0.16% | |
Caterpillar | US1491231015 | 5.56 | 366.70 | -0.24% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review